エーザイとバイオジェン、BAN2401についてプレクリニカル（無症状期）アルツハイマー病を対象とした新たな臨床第III相試験（AHEAD 3-45）を開始 Eisai Jul 14, 2020 10:00 JST Read More
Eisai: Initiation of New Phase III Clinical Study (Ahead 3-45) of ban2401 Preclinical (Asymptomatic) Alzheimer's Disease Eisai Jul 14, 2020 08:20 HKT/SGT Read More
Eisai: Industry-Academia-Government Joint Development Agreement Aiming for Drug Discovery for Systemic Lupus Erythematosus by Practical Application of Toll-Like Receptor Research Concluded Eisai Jul 13, 2020 10:47 HKT/SGT Read More
エーザイ、Toll様受容体研究の実用化による全身性エリテマトーデス治療薬の創製をめざした産学官共同研究開発契約を締結し、研究活動を開始 Eisai Jul 10, 2020 14:00 JST Read More
AIM ImmunoTech、ロズウェルパーク癌研究所と臨床試験契約を締結、COVID-19がん患者を対象とするAmpligenとインターフェロンアルファ-2bとの併用療法に関する第I/II相臨床試験を支援 AIM ImmunoTech Inc Jul 10, 2020 08:00 JST Read More
NEC Solution Innovators Establishes "FonesLife," a healthcare business company that contributes to extending healthy life expectancy NEC Corporation Jul 09, 2020 13:34 HKT/SGT Read More
Biogen Completes Submission of Biologics License Application to FDA for Aducanumab as a Treatment for Alzheimer's Disease Eisai Jul 09, 2020 11:20 HKT/SGT Read More
Eisai and Merck Receive Complete Response Letter for LENVIMA (lenvatinib) plus KEYTRUDA (pembrolizumab) Combination as First-Line Treatment for Unresectable Hepatocellular Carcinoma Eisai Jul 09, 2020 11:11 HKT/SGT Read More
エーザイとMSD、切除不能肝細胞がんに対する一次療法としてのレンバチニブとペムブロリズマブの併用療法に関し、米国FDAより審査完了通知を受領 Eisai Jul 09, 2020 11:00 JST Read More
Avance Clinical Wins Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award Avance Clinical Jul 09, 2020 01:30 JST Read More
Eisai: New Drug Application for In-House Developed New Anti-insomnia Drug Dayvigo Accepted in Hong Kong Eisai Jul 08, 2020 13:33 HKT/SGT Read More
エーザイ、抗がん剤タゼメトスタットについて日本においてEZH2遺伝子変異陽性の濾胞性リンパ腫に係る適応で新薬承認申請書を提出 Eisai Jul 08, 2020 13:30 JST Read More
Eisai Submits Marketing Authorization Application in Japan for Anticancer Agent Tazemetostat for EZH2 Gene Mutation-Positive Follicular Lymphoma Eisai Jul 08, 2020 13:16 HKT/SGT Read More
AIM ImmunoTech、国立感染症研究所および塩野義製薬とCOVID-19のワクチンアジュバント候補としてのAmpligenの試験に関する物質移動・研究契約を締結 AIM ImmunoTech Inc Jul 08, 2020 08:00 JST Read More
HOYA and Hitachi Announce Long Term Technical Collaboration and Supply Agreement Related to Endoscopic Ultrasound Systems Hitachi, Ltd. Jul 06, 2020 16:39 HKT/SGT Read More
Aichi Cancer Center and NEC Launch Joint Research on Fundamental Study Aimed at Advanced Cancer Immunotherapy NEC Corporation Jul 06, 2020 14:11 HKT/SGT Read More
